PMC, PMC5632578
Proposed mechanisms of Tesamorelin: Activates GHRH receptors Increases endogenous GH release Elevates IGF-1 production Promotes lipolysis Reduces visceral adipose tissue Why Tesamorelin is unique: Unlike most weight-loss therapies, Tesamorelin appears particularly effective at reducing visceral fat the deep abdominal fat surrounding internal organs that is strongly associated with insulin resistance, cardiovascular disease, and metabolic syndrome
Dose escalation decisions should always be made by your prescribing healthcare provider based on your individual progress, tolerability, and health status
Importantly, studies using the Broad Institute Connectivity Map have demonstrated that GHK can modulate gene expression, with observed effects on resetting pathological patterns toward healthier states
I simply cant say enough about the ease of ordering, and the products
Frequency: 3, 5 times weekly